Product registration is not enough to introduce a veterinary pharmaceutical into the Indian market. Before commercialisation, companies need to meet Veterinary Drug Regulations in India, licensing requirements, and quality standards. This guide introduces the Veterinary Drug Regulations in India and the approval process for veterinary pharmaceuticals, as well as important regulatory considerations.
Regulatory Authority for Veterinary Pharmaceuticals in India
- CDSCO and State Licensing Authorities (SLAs) is the Veterinary Pharmaceutical Regulatory Authority of India.
- New and imported veterinary drugs are approved in accordance with the Central Drugs Standard Control Organisation (CDSCO) Veterinary Regulations.
- It is regulated under the State Licensing Authority Veterinary Drug Regulations of India.
A CDSCO Authorised Agent like Artixio can help understand these regulations in detail.
Role and Responsibilities of CDSCO and State Licensing Authorities in Veterinary Drug Regulation
CDSCO Veterinary Drug Approval and import approval are governed by CDSCO. State Licensing Authorities:
- Issue manufacturing licenses
- Conduct inspections
- Monitor compliance with the Drugs and Cosmetics Act and Rules
Veterinary Pharmaceuticals Regulations in India
The Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945, are the regulatory laws for Veterinary Drug Regulations in India.
Additionally, all new drugs for use in veterinary medicine have to meet the requirements of the New Drugs and Clinical Trials Rules, 2019. These rules apply to product approval, manufacturing, imports, labelling, quality standards, and post-market compliance.
Under the Animal Health Products Regulation in India, companies are required to:
- Get CDSCO Veterinary Drug Approval prior to importation or manufacturing of a new veterinary drug.
- Before commercial production, a Veterinary Drug Manufacturing License from the State Licensing Authority must be obtained.
- Produce products in facilities meeting the Veterinary GMP Requirements in India.
- Comply with acceptable quality and product requirements.
- Comply with the Veterinary Drug Labelling Requirements in India before marketing.
- Continue to keep an eye on the safety of the product after approval and report adverse events as appropriate.
Veterinary Pharmaceuticals Registration Process in India
The Veterinary Drug Registration in India process varies based on the product type. New and imported veterinary drugs require CDSCO Veterinary Drug Approval, while manufacturing licences are issued by the respective State Licensing Authorities (SLAs). Applicants must meet all Veterinary Drug Registration Requirements in India before commercial manufacture or import.
Step 1: Determine the Regulatory Pathway
Identify whether the product is a new, generic, imported, or locally manufactured veterinary drug to determine the applicable approval pathway.
Step 2: Prepare the Dossier
Compile the required documents, including product composition, manufacturing details, quality data, stability studies, safety and efficacy data, GMP documents, and labelling.
Step 3: Conduct Clinical Studies (If required)
For new veterinary drugs, CDSCO may require clinical studies in accordance with the New Drugs and Clinical Trials Rules, 2019.
Step 4: Submit the Application
Submit the application and supporting documents to CDSCO through the SUGAM portal for regulatory review.
Step 5: Obtain Regulatory Approval
CDSCO reviews the application and may request additional information before granting approval.
Step 6: Obtain Manufacturing or Import Licence
Obtain a manufacturing licence from the State Licensing Authority or import approval from CDSCO before commercialisation.
Step 7: Meet Post-Approval Requirements
Comply with GMP, labelling, pharmacovigilance, and post-marketing surveillance requirements throughout the product lifecycle.
Documents Required for Veterinary Pharmaceuticals Registration
The documents that are needed depend on the type of application. A typical dossier will contain:
- Application in the prescribed CDSCO form
- The composition of the product and how it is made
- API specifications and finished product specifications
- Validated analytical methods
- Stability study reports
- Pharmacology and toxicology data are available
- Safety and efficacy data are not available
- Clinical study reports, as appropriate
- GMP certificate / Manufacturing licence
- Product labels and package inserts
- Product Certificate or Free Sale Certificate for imported products
- Authorisation letter by the Indian agent (if applicable)
Veterinary Clinical Trial Requirements for Pharma Products in India
The Veterinary Clinical Trial Requirements in India are primarily for new veterinary drugs. Local clinical studies will be required at the discretion of CDSCO. Trials have to be conducted with Good Clinical Practice (GCP) and regulatory requirements.
Before beginning the study, sponsors are also required to get approval from the Ethics Committee. Clinical data is a part of the review process of the New Veterinary Drug Approval in India.
Veterinary GMP Requirements for Pharma Manufacturing in India
Before the commercial production of the product, the manufacturer is required to meet the requirements of the Veterinary GMP Requirements in India. They are also required to get a Veterinary Drug Manufacturing License in India from the State Licensing Authority.
Manufacturing facilities need to meet the requirements of Schedule M of the Drugs and Cosmetics Rules. Regular inspections are made to check compliance with GMP.
Veterinary Drug Import Requirements in India
Veterinary drugs that are imported into India must be approved by the CDSCO. According to the Veterinary Drug Import Requirements of India, the applicant shall make an application for importation that typically includes:
- Providing details of the import application in the prescribed CDSCO form
- Issuing a manufacturing license and a GMP certificate
- Pharmaceutical Products Certificate or Free Sale Certificate
- Quality, safety, and efficacy information about the product
- The labels and inserts of the product have been revised
- Authorisation letter to the Indian agent
- Release batch documents (where applicable)
The applications are submitted via the CDSCO SUGAM portal. Imported products are required to be of the same standard of quality and safety as locally manufactured products.
Veterinary Pharmaceuticals Labelling Requirements
The Drugs and Cosmetics Rules, 1945, contain the Veterinary Drug Labelling Requirements in India. All veterinary drug labels should contain:
- Product name
- The amount of active ingredient as well as its strength
- Manufacturer’s name and address
- Manufacturing licence number
- Batch number
- The manufacture and expiry dates are not indicated
- Storage conditions
- Directions for use
- Caution statements and warnings are provided
Package inserts should also include the approved indications, dosage, contraindications, and other prescribing information. The labels are to be approved prior to marketing.
Timeline for Veterinary Drug Approval in India
The Veterinary Drug Approval Process in India is dependent on the type of products and the pathway of the application.
- In general, it takes around 180 days for New Veterinary Drug Approval in India after the complete acceptance of an application.
- The registration of imported items can take approximately 9 months.
- May take more time if CDSCO asks for more information or clarification.
Fees for Veterinary Pharmaceuticals Registration in India
There is an application and evaluation fee charged by CDSCO, depending on the type of application. The fee depends on:
- Product category
- Registration pathway
- Product application or manufacturing
- Regulatory review requirements
Please check the fee schedule for the most up-to-date information before applying, as fees may be subject to change at the Government’s discretion.
PMS & Pharmacovigilance Requirements for Veterinary Products
The Veterinary Pharmacovigilance Requirements in India stipulate that manufacturers and marketing authorisation holders are responsible for monitoring the safety of the products subsequent to approval. They should:
- Record adverse events
- Investigate safety complaints
- Maintain pharmacovigilance records
- Make safety reports as needed
- If safety hazards are found, take corrective measures
These activities are used to support Veterinary Drug Post-Marketing Surveillance in India throughout the product life cycle.
Conclusion
Careful planning and a clear regulatory strategy are essential to comply with Veterinary Drug Regulations in India. The reduction of approval delays can be achieved by meeting CDSCO and State Licensing Authority requirements.
Artixio enables veterinary firms to seek regulatory strategy, prepare dossiers, and engage in Veterinary Regulatory Compliance Services in India. Our experienced team guides you through the Indian regulatory landscape with confidence. For more information, get in touch with us at info@artixio.com.
FAQs
1. Which authority regulates veterinary drugs in India?
The Veterinary Pharmaceutical Regulatory Authority of India includes CDSCO and the State Licensing Authorities. CDSCO approves new and imported veterinary drugs. State Licensing Authorities issue manufacturing licences and monitor compliance.
2. What are the Veterinary Drug Registration Requirements in India?
Applicants must submit quality, safety, efficacy, manufacturing, and stability data. They should also provide GMP documents, product labels, and other supporting information required by CDSCO.
3. Is CDSCO Veterinary Drug Approval required for all veterinary drugs?
CDSCO approval is required for new veterinary drugs and imported veterinary drugs. Manufacturing licences are issued separately by the State Licensing Authority.
4. Are clinical trials required for New Veterinary Drug Approval in India?
Yes. CDSCO may require clinical studies for new veterinary drugs. The requirement depends on the product type and available supporting data.
5. What are the Veterinary Drug Import Requirements in India?
Imported veterinary drugs require CDSCO approval before marketing. Applicants must submit technical documents, GMP certificates, product quality data, and import-related documents as part of the application.
